Article
Decreased specificity of an assay for recent infection in HIV-1-infected patients on highly active antiretroviral treatment: implications for incidence estimates.
Clinical and vaccine immunology : CVI - 1 Aug 2012
Chaillon Antoine, Le Vu Stéphane, Brunet Sylvie, Gras Guillaume, Bastides Frédéric, Bernard Louis, Meyer Laurence, Barin Francis
Abstract excerpt
The aim of this study was to estimate the rate of misclassification in treated HIV patients who initiated treatment at the chronic stage of HIV infection using an enzyme immunoassay (EIA) that discriminates between recent infection (RI; within 6 months) and established infection. The performance of EIA-RI was evaluated in 96 HIV-1 chronically infected patients on highly active antiretroviral therapy (HAART) with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.